| scholarly article | Q13442814 |
| P2093 | author name string | Yuhua Wang | |
| Arash Hatefi | |||
| Brenda F. Canine | |||
| P2860 | cites work | Bacterial Cytosine Deaminase Mutants Created by Molecular Engineering Show Improved 5-Fluorocytosine-Mediated Cell Killing In vitro and In vivo | Q27655704 |
| Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity | Q33184179 | ||
| Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery | Q33280618 | ||
| Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells | Q34060541 | ||
| A designer biomimetic vector with a chimeric architecture for targeted gene transfer | Q34078983 | ||
| Clonogenic assay of cells in vitro. | Q34615431 | ||
| The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer. | Q34729437 | ||
| Prostate cancer gene therapy clinical trials | Q36779377 | ||
| Advances with the use of bio-inspired vectors towards creation of artificial viruses | Q37691446 | ||
| Designed multi-domain protein as a carrier of nucleic acids into cells | Q39927009 | ||
| Rat adenocarcinoma cell line infected with an adenovirus carrying a novel herpes-simplex virus-thymidine kinase suicide gene construct dies by apoptosis upon treatment with ganciclovir | Q40064944 | ||
| Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. | Q40481710 | ||
| Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis | Q40632272 | ||
| Nuclear localisation sequence templated nonviral gene delivery vectors: investigation of intracellular trafficking events of LMD and LD vector systems | Q40659015 | ||
| In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors | Q42818740 | ||
| Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing | Q43578068 | ||
| Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing | Q43962720 | ||
| Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy | Q45069710 | ||
| A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. | Q45739549 | ||
| Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant | Q45741033 | ||
| Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma. | Q45755851 | ||
| Development of a genetically engineered biomimetic vector for targeted gene transfer to breast cancer cells | Q47871933 | ||
| Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene | Q64379934 | ||
| A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA | Q77789524 | ||
| The effect of the structure of small cationic peptides on the characteristics of peptide-DNA complexes | Q82748637 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | suicide | Q10737 |
| gene therapy | Q213901 | ||
| P304 | page(s) | 193-200 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Nanomedicine: Nanotechnology, Biology and Medicine | Q6964073 |
| P1476 | title | HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector | |
| P478 | volume | 7 |
| Q28394647 | A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA |
| Q47403404 | Bioengineering a non-genotoxic vector for genetic modification of mesenchymal stem cells |
| Q38222535 | Controlled release from recombinant polymers |
| Q47796895 | Development of a Recombinant Multifunctional Biomacromolecule for Targeted Gene Transfer to Prostate Cancer Cells |
| Q34851586 | Development of targeted recombinant polymers that can deliver siRNA to the cytoplasm and plasmid DNA to the cell nucleus |
| Q39064497 | Enzyme/Prodrug Systems for Cancer Gene Therapy. |
| Q36534930 | Frontiers in Suicide Gene Therapy of Cancer |
| Q36592690 | Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems |
| Q34119623 | Inhibitory effects of the ultrasound-targeted microbubble destruction-mediated herpes simplex virus-thymidine kinase/ganciclovir system on ovarian cancer in mice |
| Q39139918 | Nicotinamide mononucleotide adenylyltransferase2 overexpression enhances colorectal cancer cell-kill by Tiazofurin |
| Q34553603 | Production of low-expressing recombinant cationic biopolymers with high purity. |
| Q28262370 | Progress and problems with the use of suicide genes for targeted cancer therapy |
| Q37985590 | Recombinant protein-based polymers for advanced drug delivery |
| Q92345887 | Syncytia Formation in Oncolytic Virotherapy |
| Q28817710 | Systematic engineering of uniform, highly efficient, targeted and shielded viral-mimetic nanoparticles |
| Q39456135 | Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy |
Search more.